DAVID H. PERSING

M.D., PH.D., EXECUTIVE VICE PRESIDENT, CMO & CTO, CEPHEID

Dr. Persing first joined us as a director in May 2004, and became our Executive Vice President and Chief Medical and Technology Officer in August 2005. From 1999 to 2005, Dr. Persing was Senior Vice President and Chief Scientific Officer at Corixa Corporation, a Seattle-based biotechnology company, until its acquisition by GlaxoSmithKline. Prior to that he was a member of the Clinical and Research Faculty in the Department Laboratory Medicine and Pathology at the Mayo Clinic in Rochester, Minnesota where he developed several extramurally funded infectious disease research programs. From 1992 to 1999 he established and directed the Mayo Molecular Microbiology Laboratory which was one of the first reference laboratories to offer cutting-edge molecular diagnostic testing on a worldwide basis. He has authored over 270 peer-reviewed articles including frequently cited papers in the New England Journal of Medicine, Science, and PNAS. He served as Editor in Chief for four leading textbooks on Molecular Diagnostics, the most recent of which was released in January 2011. Dr. Persing received his MD and PhD (Genetics) degrees from the University of California, San Francisco in 1988 and completed his residency training in Clinical Pathology at the Yale School of Medicine in 1990.